SCHEMBL18267223

SCHEMBL18267223

CC1(C)c2cc(-c3ccccn3)ccc2-c2cc3c4ccccc4c4ccccc4c3cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.49
▸ BRD4 O60885 1/20 0.38
▸ DHODH Q02127 1/20 0.37
▸ CTSD P07339 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CCR1 P32246 1/20 0.36
▸ CCR5 P51681 1/20 0.36
▸ CCR8 P51685 1/20 0.36
▸ METAP1 P53582 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17206440 0.95 PDK2 (0.45) PDK2BRD4DHODHCTSDBACE1
SCHEMBL18267225 0.93 PDK2 (0.42) PDK2BRD4DHODHCTSDBACE1
SCHEMBL17426592 0.91 PDK2 (0.49) PDK2BRD4DHODHCTSDBACE1
SCHEMBL17206476 0.91 KDM4E (0.45) PDK2BRD4DHODHCTSDBACE1
SCHEMBL13388806 0.89 PDK2 (0.57) PDK2BRD4CTSDBACE1KDM4E
SCHEMBL17206415 0.88 PDK2 (0.44) PDK2BRD4DHODHBACE1PRMT5
SCHEMBL17206419 0.86 PDK2 (0.43) PDK2BRD4DHODHKDM4ENPC1
SCHEMBL30772301 0.85 PDK2 (0.61) PDK2CTSDBACE1KDM4ENPC1
SCHEMBL3392580 0.85 PDK2 (0.61) PDK2CTSDBACE1KDM4ENPC1
SCHEMBL17206425 0.84 PDK2 (0.44) PDK2BRD4DHODHKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9893305-B2 Indenotriphenylene-based iridium complexes for organic electroluminescence device UDC IRELAND LIMITED (IE) 2018-02-13 — — US disclosed
US-9893305-B2 Indenotriphenylene-based iridium complexes for organic electroluminescence device UDC IRELAND LIMITED (IE) 2018-02-13 — — US disclosed
US-20160351835-A1 INDENOTRIPHENYLENE-BASED IRIDIUM COMPLEXES FOR ORGANIC ELECTROLUMINESCENCE DEVICE UDC IRELAND LIMITED (IE) 2016-12-01 — — US disclosed
US-20160351835-A1 INDENOTRIPHENYLENE-BASED IRIDIUM COMPLEXES FOR ORGANIC ELECTROLUMINESCENCE DEVICE UDC IRELAND LIMITED (IE) 2016-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351835-A1 INDENOTRIPHENYLENE-BASED IRIDIUM COMPLEXES FOR ORGANIC ELECTROLUMINESCENCE DEVICE CHRM1, IDO1, CCNE2 PDK2 806/4885BRD4 81/4885DHODH 1907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback